Market data
Medical Conditions Disorders
Explore verified medical conditions disorders statistics and market research reports with sourced data and trend analysis.
Latest update:
Elif Demirci
Heart Murmur Statistics
Heart murmurs aren’t rare, but the odds swing fast once you factor in age and whether the murmur is found in a screening setting, with 2026 data showing diagnosis and referral patterns that look markedly different from what many people assume. Get the key statistics that explain who is most affected, how often follow-up actually happens, and why the “harmless” label can be surprisingly misleading.
Brain Injury Statistics
TBI can affect more than 1 in 10 people when you include long-term consequences, including 8.5% of U.S. adults with a reported history of TBI and a 16% PTSD symptom rate among people with TBI. This page also weighs real treatment impact against real-world burden, from pooled cognitive rehab gains and rTMS evidence to the stark gap between mortality and rehabilitation timelines, plus today’s neurorehab market momentum and costs.
Coronavirus Cases Statistics
Track how Coronavirus Cases are moving right now, with the latest totals and daily shifts side by side so you can spot what is changing and what is not. It is a quick way to compare today’s impact against the recent baseline and see whether the trend is easing or tightening.
Hemophilia Statistics
See how hemophilia care is changing in real numbers, with 2025 rates of people living with the condition and updated treatment access figures that show where progress is landing. The page also highlights the gap between expected bleeding risk and what patients can actually manage, using the latest reported statistics to sharpen what matters next.
Bladder Cancer Statistics
Even a small bladder tumor can change everything, and the latest bladder cancer statistics highlight just how quickly risk and outcomes can diverge by sex and stage. Read the page to see where rates are headed in 2025 and which numbers consistently separate early detection from late diagnosis.
Cml Statistics
Cml’s latest numbers show where the momentum is really coming from as 2026 data points reveal a sharper shift than last year. You’ll see which segments are accelerating and which are slipping, all in a tight snapshot designed to make the implications obvious fast.
Irritable Bowel Syndrome Statistics
IBS affects far more than the “just stress” stereotype, with about 1 in 10 adults living with it, yet many never get a clear diagnosis. The statistics also highlight how symptoms like abdominal pain and altered bowel habits can reshape daily life, and where the newest treatment and care patterns still leave gaps.
Clabsi Statistics
See how Clabsi rates are changing right now, including the latest 2025 figures that reveal which units are tightening or slipping. The contrast between facility level trends and what happens at the bedside makes it clear where prevention effort should focus next.
Toxic Shock Syndrome Statistics
Even today, toxic shock syndrome can be deadly without prompt care, with 30% to 50% of patients dying, yet classic menstrual cases now sit around 0.03 to 0.25 per 100,000 as practice and recognition improved. This statistics page puts the urgency next to the biology and treatment evidence, from TSST 1 to clindamycin and IVIG outcomes, so you can see why early toxin targeting and rapid source control matter as much as incidence.
Bone Cancer Statistics
Bone cancer is rare overall, but it is disproportionately a young person’s cancer, with 34% of cases diagnosed before age 20 and about 1.0 per 100,000 age adjusted incidence in the U.S. Lung is the most common distant metastasis site and survival drops from 71% for localized disease to 27% once it has spread, making the difference between “where it starts” and “where it goes” central to outcomes, with 1,040 new cases and 540 expected deaths in 2024.
Bone Marrow Cancer Statistics
In 2020, the United States estimated 32,270 new multiple myeloma cases and 12,830 deaths, with the median diagnosis age at 69 and survival falling from 66.7% at 2 years to 54.5% at 5 years. Yet incidence is rising and outcomes vary sharply by age and race, so the page puts the “bone marrow cancer” reality of who gets multiple myeloma, when, and why it hits hardest in older age groups into one current, decision ready snapshot.
Syphilis Statistics
Syphilis still drives stark outcomes, from 11,000 deaths globally in 2019 to 1.6 million pregnancy losses and stillbirths each year tied to untreated maternal infection. You will also see where prevention can tighten fast, including the US 30.6% rise in congenital syphilis from 2018 to 2022 and how same day screening and treatment could cut congenital syphilis burden by 63% by 2030.
Alzheimers Disease Statistics
From 2025 forward, the facts stay sobering as dementia claims an estimated 1% of the global burden of disease and 2% of deaths worldwide, while Alzheimer’s ranks as the 6th leading cause of death in the United States. This page also brings the financial pressure into focus with US dementia out of pocket spending at $20.3 billion in 2020 and projects major market momentum for diagnosis and therapeutics, so you can see why prevention and better care can’t wait.
Crps Statistics
From Budapest criteria and QST to skin biopsy and QSART, this page ties together high-signal diagnostics with modern sensitivity like IASP criteria at 98% sensitivity and EMG distinguishing CRPS II from CRPS I. It also pairs that clarity with outcomes and risk you can act on fast, since diagnosis within 3 months improves recovery in 80% and early recognition beats the long tail of chronic spread and disability.
Sarcoma Statistics
From MRI accuracy over 90% for local staging to biopsy and PET CT thresholds that can change the entire treatment pathway, this page turns sarcoma workups into usable, decision level facts. It also spotlights where outcomes sharply diverge, including 80% 5 year survival for localized disease dropping to 15% when metastases are present at diagnosis, plus cutting edge 2023 US incidence figures of 13,590 new soft tissue sarcoma cases.
Meningitis Statistics
Classic fever, neck stiffness, and altered mental status appear in only 44 percent of adult bacterial meningitis cases, while CSF pleocytosis shows up in about 90 percent and Gram stain is positive in 60 to 90 percent. This page pulls together up to date global burden and lab realities, including 2.47 million cases and 251,000 deaths worldwide in 2019, so you can see how recognition and testing translate into outcomes.
Narcolepsy Statistics
Narcolepsy can be traced to a loss of hypocretin neurons in about 90% of type 1 cases, yet the risk profile is far from uniform, from a 6 fold spike after Pandemrix in children to genetic and immune signals like HLA DQB1 06:02 in up to 98% and autoimmune destruction suspected in 70 to 80% of sporadic cases. This page puts prevalence and everyday impact side by side, with around 25 to 50 per 100,000 people worldwide living under a disorder marked by accident risk 2 to 10 times higher in untreated patients.
ADHD Medication Shortage Statistics
A 2025 Frontiers in Pharmacology qualitative review of Reddit posts shows US ADHD shortages forcing patients to drive long distances and even push some toward self medicating when methylphenidate runs out. In the UK, a 2025 All Party Parliamentary Group survey found more than 9 in 10 pharmacists, GPs and prescribers reporting ADHD medicines affected, turning a treatment disruption into worsening mental health, withdrawal symptoms, and daily life breakdowns for families who cannot afford delays.
Speech And Language Disorders Statistics
Nearly 7.7% of U.S. children aged 3 to 17 have a speech or language disorder, and the page shows how risks can multiply fast across biology, environment, and access. Read how prematurity raises speech risk 2.5 times, low socioeconomic status triples persistent impairments, and why rural families get speech language therapy 30% less often despite measurable, testable delays.
Dual Diagnosis Statistics
With 9.2 million U.S. adults aged 18 and older living with both mental illness and a substance use disorder, dual diagnosis is far more common than most people assume, and the risk gaps are stark. This page pinpoints who is most affected and why outcomes swing fast with integrated care, where full SUD remission reaches 35% at two years while untreated dual diagnosis can trigger 90% relapse within a year.